Literature DB >> 6139711

Desferrioxamine and systemic yersiniosis.

R M Robins-Browne, J K Prpic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6139711     DOI： 10.1016/s0140-6736(83)91136-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

Review 1.  The critical role of iron in some clinical infections.

Authors:  J J Bullen; C G Ward; H J Rogers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-08       Impact factor: 3.267

2.  Infection with Yersinia enterocolitica in patients with iron overload.

Authors:  H Y Chiu; D M Flynn; A V Hoffbrand; D Politis
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-11

Review 3.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Congenital sideroblastic anaemia in two girls.

Authors:  G Dolan; M M Reid
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

Review 5.  World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors:  Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-09-26

6.  Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection.

Authors:  S Schubert; I B Autenrieth
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine.

Authors:  M Nakamura; W B Weil; D B Kaufman
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

8.  Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review.

Authors:  Rebecca L C Adams; Robert J Bird
Journal:  Ther Adv Hematol       Date:  2013-04

Review 9.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload.

Authors:  Y Waterlot; B Cantinieaux; C Hariga-Muller; E De Maertelaere-Laurent; J L Vanherweghem; P Fondu
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.